International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released May 14, 2024, after the close
10-Q filed May 14, 2024, 44 days after period end · 0000950170-24-059478
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $2.13M | $2.09M | $2.02M | $1.66M |
| Net Income | -$214.00K | -$34.00K | -$9.00K | -$599.00K |
| EPS Diluted | -$0.03 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
